Reversed-phase liquid chromatography method to determine COL-3, a matrix metalloproteinase inhibitor, in biological samples
10.1016/j.jchromb.2003.10.066
Saved in:
Main Authors: | Li, J., Huynh, H., Chan, E. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/106308 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicin
by: Li, J., et al.
Published: (2014) -
Pre-clinical studies on pharmacokinetics and pharmacodynamics of col-3, a matrix metalloproteinase inhibitor: Single agent and in combination with doxorubicin
by: LI JING
Published: (2019) -
Evidence for dissolution rate-limited absorption of COL-3, a matrix metalloproteinase inhibitor, leading to the irregular absorption profile in rats after oral administration
by: Li, J., et al.
Published: (2014) -
The role of matrix metalloproteinases (MMP) and their inhibitor in influenza A virus-induced host lung injury
by: NG HUEY HIAN
Published: (2011) -
Significant intestinal excretion, one source of variability in pharmacokinetics of COL-3, a chemically modified tetracycline
by: Li, J., et al.
Published: (2014)